Pharmagreen Biotech Inc.
PHBI
$0.0011
$0.000.00%
| Weiss Ratings | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.98 | |||
| Price History | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -56.00% | |||
| 60-Day Total Return | -31.25% | |||
| 90-Day Total Return | -52.17% | |||
| Year to Date Total Return | -31.25% | |||
| 1-Year Total Return | 57.14% | |||
| 2-Year Total Return | -77.08% | |||
| 3-Year Total Return | -90.00% | |||
| 5-Year Total Return | -99.56% | |||
| 52-Week High % Change | -76.60% | |||
| 52-Week Low % Change | 83.33% | |||
| Price | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 13, 2024 | |||
| 52-Week High Price (Date) | Sep 25, 2024 | |||
| Valuation | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 730.01K | |||
| Enterprise Value | 1.03M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -71.43% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.31 | |||
| Enterprise Value/Revenue (TTM) | 344.93 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -4.41 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 663.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 803 9404 | |||
| Address | 2987 Blackbear Court Coquitlam, BC V3E 3A2 | |||
| Website | www.pharmagreen.ca | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -7,813.33% | |||
| Profit Margin | -7,543.33% | |||
| Management Effectiveness | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -139.13% | |||
| Return on Equity | -- | |||
| Income Statement | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.00K | |||
| Total Revenue (TTM) | 3.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 1.30K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -234.40K | |||
| Net Income (TTM) | -226.30K | |||
| Net Income Avl. to Common (TTM) | -226.30K | |||
| Total Revenue Growth (Q YOY) | -33.33% | |||
| Earnings Growth (Q YOY) | 537.06% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 600.00% | |||
| Balance Sheet | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 900.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 98.20K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -2.40M | |||
| Current Ratio (Q) | 0.041 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 98.20K | |||
| Total Current Liabilities (Q) | 2.41M | |||
| Total Debt (Q) | 352.40K | |||
| Total Liabilities (Q) | 2.50M | |||
| Total Common Equity (Q) | -2.35M | |||
| Cash Flow | PHBI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 42.20K | |||
| Net Change in Cash (TTM) | 100.00 | |||
| Levered Free Cash Flow (TTM) | -161.00K | |||
| Cash from Operations (TTM) | -33.00K | |||
